Biolitec Research GmbH
Records under this name other than the patents Biolitec Research GmbH holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 1 patents it holds.
Showing 1 to 1 of 1 · Back to Biolitec Research GmbH
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,815,931 | Oral Formulations for Tetrapyrrole Derivatives now held by Biolitec Unternehmensbeteiligungs II AG Lapsed on the fee record Ended Aug 26, 2026 · High confidence | Lapsed on the fee record | Ended Aug 26, 2026 | High confidence |